Immunization News and Research

RSS

Health Canada approves Prevnar 13 vaccine for invasive pneumococcal disease

Following a Priority Review, Health Canada has approved Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)) for children aged six weeks through five years for active immunization against invasive pneumococcal disease, a bacterial infection that can include meningitis (inflammation of the coverings of the brain and spinal cord), sepsis (bloodstream infection), bacteremic pneumonia, pleural empyema (accumulation of pus in the cavity surrounding the lungs) and bacteremia (bacteria in the blood).

22 Dec 2009

Study results of CSL’s pandemic H1N1 2009 vaccine published in JAMA

CSL Limited, Australia’s leading biopharmaceutical company, announced the Journal of the American Medical Association (JAMA) has published data from a clinical trial conducted in Australia to study CSL’s pandemic H1N1 2009 ‘swine’ flu vaccine.

22 Dec 2009

NMA urges parents to protect their children from meningococcal disease

This winter, while many parents are focused on influenza prevention, the National Meningitis Association (NMA) is urging parents to also protect their families from meningococcal disease, a deadly but potentially vaccine preventable bacterial infection.

22 Dec 2009

One dose of vaccine may be effective to protect infants and children from H1N1 virus, shows study

One dose of vaccine may be effective to protect infants and children and reduce transmission of the H1N1 virus, according to a study in JAMA, published online today because of its public health implications. The study will appear in the January 6 print edition of the journal.

21 Dec 2009

Positive interim results from Medicago's H5N1 vaccine Phase I human clinical trial

Medicago Inc. a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase I human clinical trial with its H5N1 Avian Influenza vaccine candidate ("H5N1 vaccine"). The vaccine was found to be safe, well tolerated and also induced a solid immune response.

21 Dec 2009

Duane Reade offers H1N1 immunization vaccines for New York residents

Duane Reade, the largest drug store chain in New York City, today announced plans for its H1N1 immunization program as part of the Company's commitment to meet the health and wellness needs of New Yorkers and to be a destination for their flu related needs.

18 Dec 2009

Opinions: HIV prevention; PEPFAR; H1N1 vaccine donation; developing country R&D; climate change

"For nearly 30 years scientists have been trying to break the back of the AIDS epidemic," but the recent microbicide gel study and an AIDS vaccine trial in Thailand "show just how difficult and how distant that goal is," according to a Washington Post editorial. "While scientists continue searching for a vaccine or a cure, prevention remains paramount," the Washington Post concludes (12/16).

16 Dec 2009

WHO using new bivalent oral polio vaccine in Afghanistan

The WHO on Tuesday launched a vaccination campaign in Afghanistan that will use "a new and more effective polio vaccine" for the first time, Reuters reports (Nebehay, 12/15).

16 Dec 2009

U.S. patent for new bioadhesive drug delivery system awarded to SRI International

SRI International, an independent nonprofit research and development organization, announced today the award of U.S. patent 7,592,021 for a new bioadhesive drug delivery system that enables enhanced release of drugs through the human body's mucous membranes.

16 Dec 2009

Wild poliovirus reaches more African countries in 2009, WHO official says

Cases of polio have been reported in some African countries that have eradicated the disease, Luis Gomes Sambo, the WHO's Africa regional director, said Monday at the opening of a child immunisation conference in Zimbabwe, Agence France-Presse reports (12/14). It is the WHO's first annual regional conference on immunization, according to VOA News. Sambo said the conference will review the status of immunization in the 46-country sub-Saharan region (Mafundikwa, 12/14).

15 Dec 2009

Researchers advance in developing a vaccine against AIDS disease

Led by Matthias J. Schnell, Ph.D., director of the Jefferson Vaccine Center, the researchers found that a rabies virus-based vaccine administered to monkeys protected against the simian equivalent of the HIV virus (SIV). The data were published in the journal Vaccine.

15 Dec 2009

Researchers to receive more than $4.5 million in grants to study Sudden Infant Death Syndrome

Researchers at the Los Angeles Biomedical Research Institute (LA BioMed) expect to receive more than $4.5 million in grants from the American Recovery and Reinvestment Act (Recovery Act.), including nearly $1 million from the highly competitive Challenge Grant program for a study that seeks to reduce the number of children who die from Sudden Infant Death Syndrome, it was announced today.

15 Dec 2009

Pulse EHR receives 2011 CCHIT Comprehensive certification

To receive the 2011 CCHIT Comprehensive certification, the Pulse EHR had to undergo a rigorous inspection of integrated functionality, interoperability and security, in addition to achieving full compliance with proposed federal standards tied to ARRA “meaningful use” financial incentives.

14 Dec 2009

National Vaccine Plan aims to protect Americans from vaccine-preventable illnesses

While vaccines help prevent many diseases in the United States, we lack immunization protection against several serious illnesses, says a new report from the Institute of Medicine that identifies priority areas for updating the National Vaccine Plan.

14 Dec 2009

Pfizer's Prevenar 13 granted European marketing authorization

The European Commission has granted Pfizer Inc. a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13 (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]). Prevenar 13 is indicated for active immunization for the prevention of invasive disease, pneumonia, and acute otitis media caused by 13 Streptococcus pneumoniae serotypes in infants and children from 6 weeks to 5 years of age. Invasive pneumococcal disease includes sepsis, meningitis, bacteremia, bacteremic pneumonia, and empyema.

11 Dec 2009

Study reveals increased discussion on flu vaccines has no significant impact on public's behavior

Seasonal flu vaccination rates among American adults have only slightly improved over last year, despite increased public discussion of the importance of influenza vaccines resulting from the worldwide outbreak of the H1N1 virus.

10 Dec 2009

Macomb County Health Department opens new H1N1 influenza immunization clinics

Sfter holding more than a dozen H1N1 influenza immunization clinics this fall targeting people in high-risk groups, the Macomb County Health Department announced today that it is opening its upcoming clinics to everyone 6 months of age and older.

9 Dec 2009

CPS calls for national child poverty strategy to address disparities in income and opportunities

The Canadian Paediatric Society is calling upon governments at all levels to commit themselves to ending child and youth poverty in Canada. As part of its new report, Are We Doing Enough?, the CPS calls for a national child poverty strategy, with provincial/territorial targets and timetables to address disparities in income and opportunities.

9 Dec 2009

ADVocacy for IMmunization program receives a three-year grant from the Bill & Melinda Gates Foundation

The Agence de Médecine Préventive (AMP) has received a three-year grant from the Bill & Melinda Gates Foundation to implement a program to support immunization advocacy in West Africa.

8 Dec 2009

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.

8 Dec 2009

Immunization News and Research

Health Canada approves Prevnar 13 vaccine for invasive pneumococcal disease

Study results of CSL’s pandemic H1N1 2009 vaccine published in JAMA

NMA urges parents to protect their children from meningococcal disease

One dose of vaccine may be effective to protect infants and children from H1N1 virus, shows study

Positive interim results from Medicago's H5N1 vaccine Phase I human clinical trial

Duane Reade offers H1N1 immunization vaccines for New York residents

Opinions: HIV prevention; PEPFAR; H1N1 vaccine donation; developing country R&D; climate change

WHO using new bivalent oral polio vaccine in Afghanistan

U.S. patent for new bioadhesive drug delivery system awarded to SRI International

Wild poliovirus reaches more African countries in 2009, WHO official says

Researchers advance in developing a vaccine against AIDS disease

Researchers to receive more than $4.5 million in grants to study Sudden Infant Death Syndrome

Pulse EHR receives 2011 CCHIT Comprehensive certification

National Vaccine Plan aims to protect Americans from vaccine-preventable illnesses

Pfizer's Prevenar 13 granted European marketing authorization

Study reveals increased discussion on flu vaccines has no significant impact on public's behavior

Macomb County Health Department opens new H1N1 influenza immunization clinics

CPS calls for national child poverty strategy to address disparities in income and opportunities

ADVocacy for IMmunization program receives a three-year grant from the Bill & Melinda Gates Foundation

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News